Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Mayne Pharma Group Limited

Mayne Pharma is an ASX-listed specialty pharmaceutical company focused on commercialising pharmaceuticals. The company has a track record of innovation and success in developing new oral drug delivery systems.

msh id	COM:MAYNEPHARMA
symbol	MYX
name	Mayne Pharma Group Limited
homepage url	https://www.maynepharma.com
country	AU
sector	Healthcare
industry	Drug Manufacturers - General
market	STOCKS
employee count	850
crunchbase url	-
linkedin url	-
founders	-

market cap	237.82M
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	3.58K
monthly webtraffic growth	-0.6
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.33
growth cost of revenue	0.18
growth depreciation and amortization	0.19
growth ebitda	-0.81
growth ebitda ratio	-0.55
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.1
growth gross profit	0.13
growth gross profit ratio	-0.03

MYX

COM:MAYNEPHARMA

Mayne Pharma

Last Close

4.18

22/11 05:10

Market Cap

362.42M

Beta: -

Volume Today

259.52K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	244.96M
cost of revenue	244.96M
depreciation and amortization	43.32M
ebitda	-80.1M
ebitda ratio	-0.66
eps	-2.43
eps diluted	-2.43
operating expenses	141.19M
operating income	-123.43M
operating income ratio	-1.02

accounts receivables	78.58M
capital expenditure	-145.37M
cash at beginning of period	64.27M
cash at end of period	67.33M
inventory	72.1M
working capital ttm	-98.8M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-